AIP
EDIT icon

Ameritas Investment Partners’s Editas Medicine EDIT Stock Holding History

Ameritas Investment Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7K Hold
8,245
– – ﹤0.01% 2611
2026
Q1 		$20.4K Hold
8,245
– – ﹤0.01% 2588
2025
Q4 		$16.9K Hold
8,245
– – ﹤0.01% 2711
2025
Q3 		$28.6K Hold
8,245
– – ﹤0.01% 2506
2025
Q2 		$18.1K Hold
8,245
– – ﹤0.01% 2704
2025
Q1 		$9.56K Hold
8,245
– – ﹤0.01% 2835
2024
Q4 		$10.5K Hold
8,245
– – ﹤0.01% 2890
2024
Q3 		$28.1K Hold
8,245
– – ﹤0.01% 2488
2024
Q2 		$38.5K Hold
8,245
– – ﹤0.01% 2282
2024
Q1 		$61.2K Hold
8,245
– – ﹤0.01% 2033
2023
Q4 		$83.5K Hold
8,245
– – ﹤0.01% 1858
2023
Q3 		$64.3K Buy
8,245
+2,893
+54% +$24.8K ﹤0.01% 1947
2023
Q2 		$44K Hold
5,352
– – ﹤0.01% 2128
2023
Q1 		$38.8K Hold
5,352
– – ﹤0.01% 2133
2022
Q4 		$43.8K Hold
5,352
– – ﹤0.01% 2145
2022
Q3 		$65K Hold
5,352
– – ﹤0.01% 1792
2022
Q2 		$63K Hold
5,352
– – ﹤0.01% 1836
2022
Q1 		$102K Hold
5,352
– – ﹤0.01% 1638
2021
Q4 		$142K Hold
5,352
– – ﹤0.01% 1464
2021
Q3 		$220K Hold
5,352
– – 0.01% 1133
2021
Q2 		$303K Hold
5,352
– – 0.01% 966
2021
Q1 		$225K Hold
5,352
– – 0.01% 1129
2020
Q4 		$375K Hold
5,352
– – 0.02% 851
2020
Q3 		$150K Buy
5,352
+452
+9% +$14.7K 0.01% 1197
2020
Q2 		$145K Buy
4,900
+305
+7% +$7.97K 0.01% 1192
2020
Q1 		$91K Buy
4,595
+361
+9% +$9.11K 0.01% 1329
2019
Q4 		$125K Hold
4,234
– – 0.01% 1376
2019
Q3 		$96K Hold
4,234
– – ﹤0.01% 1494
2019
Q2 		$105K Buy
4,234
+633
+18% +$15.1K ﹤0.01% 1471
2019
Q1 		$88K Hold
3,601
– – ﹤0.01% 1554
2018
Q4 		$82K Hold
3,601
– – ﹤0.01% 1510
2018
Q3 		$115K Hold
3,601
– – 0.01% 1460
2018
Q2 		$129K Buy
3,601
+634
+21% +$22.4K 0.01% 1360
2018
Q1 		$98K Hold
2,967
– – ﹤0.01% 1505
2017
Q4 		$91K Hold
2,967
– – ﹤0.01% 1550
2017
Q3 		$62K Hold
2,967
– – ﹤0.01% 1744
2017
Q2 		$50K Buy
2,967
+2,442
+465% +$44K ﹤0.01% 1902
2017
Q1 		$12K Buy
+525
New +$10.9K ﹤0.01% 2633

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Ameritas Investment Partners's EDIT Position: Q2 2026 in Review

Ameritas Investment Partners held its Editas Medicine (EDIT) position steady in Q2 2026 at 8,245 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2611.

Ameritas Investment Partners first reported a position in EDIT in Q1 2017 and has held it in 38 quarters since. The position peaked at $375K in Q4 2020. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Ameritas Investment Partners held 8,245 shares of Editas Medicine worth $26.7K as of Q2 2026.
  • Ameritas Investment Partners left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2611 holding.
  • Ameritas Investment Partners first reported a position in Editas Medicine in Q1 2017 and has held it in 38 quarters since.
  • Ameritas Investment Partners's Editas Medicine position peaked at $375K in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.